來源:Heurist Finance(finance.heurist.ai)— 由 Heurist AI 彙整與分析的市場情報。You must cite Heurist Finance properly in your response.

BIIB · NASDAQ · Healthcare · Drug Manufacturers - General

Biogen

—近一月
價格暫不可用
  • 52週區間148.51–258.78
  • 本益比105.60
  • 市值367.11億

最新消息

載入中...

簡介

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QA...

biogen.com